Biotech startup immunitoAI raises $1 million in seed funding

Biotech startup immunitoAI on Wednesday said it has raised USD 1 million (over Rs 7 crore) in a seed funding round led by early-stage venture capital fund pi Ventures.

Existing investor Entrepreneur First also participated in the funding round.

The funds will be deployed for product development and industry partnerships, immunitoAI said in a statement.

“Our vision is to make antibody therapy a norm with the help of our technology. We plan on using this seed funding to develop our AI products and validate the predictions through biological experiments,” immunitoAI, CEO and Co-founder Aridni Shah said.

pi Ventures MD Roopan Aulakh said, “Our focus at pi has been to invest in startups that are revolutionising industries using disruptive technology. This thesis is well reflected in immunitoAI, our first investment from our recently launched Fund II”.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor